Chlorpheniramine + Dextromethorphan
Composition
This formulation contain combination of Chlorpheniramine and Dextromethorphan as active agent
Indications
the symptomatic relief of cough and associated symptoms of upper respiratory tract infections, including the common cold, allergic rhinitis, and sinusitis
Side effects
drowsiness, dizziness, dry mouth, blurred vision, and gastrointestinal disturbances
Precautions
caution in individuals with a history of respiratory conditions such as asthma or chronic obstructive pulmonary disease
Contraindications
It should also be avoided in children under the age of 6 years, pregnant women, and breastfeeding mothers
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet, Capsule, Syrup
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai